Overactive Bladder Syndrome
110
11
13
46
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
7.3%
8 terminated out of 110 trials
85.2%
-1.3% vs benchmark
29%
32 trials in Phase 3/4
20%
9 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 46 completed trials
Clinical Trials (110)
Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application
Impact of TTNS on Bladder Symptoms Among People With MS, A RCT
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
rTMS in Overactive Bladder
Moving Beyond p-Values: MCID for OAB-V8 8 and ICIQ-SF in Patients With OAB
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study
Role of Combination Therapy in Women With Refractory Overactive Bladder
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Oxybutynin for Post-surgical Bladder Pain and Urgency
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
Improving Overactive Bladder Treatment Access and Adherence
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
Migraine Medication Effects on Urinary Symptoms
Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial
Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial